By helping manage difficult to diagnose conditions that have small patient populations, we are transforming disease management and treatment for the first time at the level of the individual, where the cohorts cannot be easily determined.
Our capability provides enabling content and insight for our customers to bring value to payers and patients through significantly earlier diagnosis and accurate targeting and to apply healthcare solutions for a more efficient and cost-effective market access strategy.
Back to News
To define a new market you need to first understand it, Volv builds your understanding and then your tools to address your new markets for Rare Diseases and Personalised Medicines
